Publicaciones en colaboración con investigadores/as de Pfizer (United States) (6)

2011

  1. Inappropriate overuse of inhaled corticosteroids for COPD patients: Impact on health costs and health status

    Lung, Vol. 189, Núm. 3, pp. 199-206

  2. Risk factors for asthma onset between the ages of 12 and 40. results of the FENASMA study

    Archivos de Bronconeumologia, Vol. 47, Núm. 9, pp. 433-440

2010

  1. The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings

    BMC Cardiovascular Disorders, Vol. 10

2009

  1. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective

    BMC Pulmonary Medicine, Vol. 9

  2. Health, treatment and health care resources consumption profile among Spanish adults with diabetes and chronic obstructive pulmonary disease

    Primary Care Diabetes, Vol. 3, Núm. 3, pp. 141-148

2008

  1. Determinants and predictors of the cost of COPD in primary care: A Spanish perspective

    International Journal of COPD, Vol. 3, Núm. 4, pp. 701-712